Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 365

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 365
---
 |                   – |     |                 161 |   |     |             – |     |       – |     |                         – |   |     |                161 |   |
| Costs associated with share issue on 19 February 2021 |     | 14,21 |     |                   – |     |                 (10 | ) |     |             – |     |       – |     |                         – |   |     |                (10 | ) |
| Shares issued on 6 July 2021                          |     | 14,21 |     |                  35 |     |               9,965 |   |     |             – |     |       – |     |                         – |   |     |             10,000 |   |
| Costs associated with share issue on 6 July 2021      |     | 14,21 |     |                   – |     |              (1,046 | ) |     |             – |     |       – |     |                         – |   |     |             (1,046 | ) |
| Share-based payment charge                            |     |       |     |                   – |     |                   – |   |     |             – |     |       – |     |                        89 |   |     |                 89 |   |
| Total contribution by and distributions to owners     |     |       |     |                  35 |     |               9,070 |   |     |             – |     |       – |     |                        89 |   |     |              9,194 |   |
| At 31 December 2021                                   |     |       |     |               1,098 |     |              83,434 |   |     |        53,003 |     |     720 |     |                  (127,803 | ) |     |             10,452 |   |

| F-30 |

Notes
forming part of the financial statements

For the years ended 31 December
2023, 2022 and 2021

| 1 | Accounting policies |

General information

Biodexa Pharmaceuticals
PLC (the ‘Company’) is a company registered and domiciled in England and Wales. The Company was incorporated on 12 September
2014.

The Company is a public
limited company, whose ordinary shares were admitted to trading on AIM (‘AIM’), which is a submarket of the London Stock Exchange,
on 8